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Abstract: Manipulating dietary macronutrient intake may modulate adaptive responses to exercise,
and improve endurance performance. However, there is controversy as to the impact of short-term
dietary modification on athletic performance. In a parallel-groups, repeated measures study, 16
trained endurance runners (maximal oxygen uptake (
.
VO2max): 64.2 ± 5.6 mL·kg−1·min−1) were
randomly assigned to, and provided with, either a high-protein, reduced-carbohydrate (PRO) or
a high-carbohydrate (CHO) isocaloric-matched diet. Participants maintained their training load
over 21-consecutive days with dietary intake consisting of 7-days habitual intake (T1), 7-days
intervention diet (T2) and 7-days return to habitual intake (T3). Following each 7-day dietary period
(T1–T3), a micro-muscle biopsy was taken for assessment of gene expression, before participants
underwent laboratory assessment of a 10 km treadmill run at 75%
.
VO2max, n treadmill run at 70%
v
.
VO2max time to exhaustion (TTE) trial. The PRO diet resulted in a modest change (1.37-fold increase,
p = 0.016) in AMPK expression, coupled with a significant increase in fat oxidation (0.29 ± 0.05 to
0.59 ± 0.05 g·min−1, p < 0.0001). However, a significant reduction of 23.3% (p = 0.0003) in TTE post
intervention was observed; this reverted back to pre levels following a return to the habitual diet. In
the CHO group, whilst no change in sub-maximal fuel utilisation occurred at T2, a significant 6.5%
increase in TTE performance (p = 0.05), and a modest, but significant, increase in AMPK (p = 0.042)
and PPAR (p = 0.029) mRNA expression compared to T1 were observed; with AMPK (p = 0.011)
and PPAR (p = 0.044) remaining significantly elevated at T3. In conclusion, a 7-day isocaloric high
protein diet significantly compromised high intensity exercise performance in trained runners with
no real benefit on gene markers of training adaptation. A significant increase in fat oxidation during
submaximal exercise was observed post PRO intervention, but this returned to pre levels once the
habitual diet was re-introduced, suggesting that the response was driven via fuel availability rather
than cellular adaptation. A short-term high protein, low carbohydrate diet in combination with
endurance training is not preferential for endurance running performance.
Keywords: protein; AMPK; PGC-1α; substrate oxidation; dietary intake; endurance performance;
runners
1. Introduction
A number of factors can influence endurance performance, including body mass, aer-
obic and anaerobic capacity, running efficiency, fuel utilisation and energy metabolism [1].
The manipulation of dietary intake has become a popular intervention to target a number
of these determinates. A critical component to these factors is mitochondrial function; with
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mitochondrial efficiency, density and abundance being linked with improved aerobic capac-
ity, exercise efficiency and energy metabolism [2]. Mitochondria are regulated by a number
of mechanisms including fission, fusion, autophagy and biogenesis. Puigserver et al. [3]
first isolated and identified peroxisome proliferator-activated receptor gamma coactivator
1-alpha (PGC-1α) as having a key functional role in the regulation of mitochondrial pro-
cesses. It has since been established that a series of transcriptional genes play an essential
role in the activation of mitochondrial biogenesis and fatty acid oxidation including: 5′
adenosine monophosphate-activated protein kinase (AMPK), silent information regulator
(SIRT1), peroxisome proliferator-activated receptors (PPAR) and PGC-1α [4–6]. As such,
nutritional interventions (such as increasing energy expenditure [7,8] and manipulating
carbohydrate availability [9]), targeting these transcriptional genes have been developed to
improve mitochondrial function.
A substantial body of evidence has demonstrated that SIRT1 and AMPK both respond
to increases in energy expenditure [7,8] and reduced carbohydrate availability [9]. In
addition, it has been suggested that increased dietary carbohydrate intake prevents the
activation of the AMPK-SIRT1 axis in skeletal muscle, potentially down-regulating the
metabolic pathway, which may blunt acute adaptations to exercise [4,10,11]. Endurance
exercise is well established as a potent stimulator of PGC-1α [12,13] both independently
and combined with exercising in a low glycogen state [14]. Restricting dietary carbohydrate
intake (or training in an acutely depleted state, the ‘train-low, perform-high’ approach)
to enhance the adaptation from physical training has been proposed as an effective short-
term strategy to enhance metabolic and cellular adaptations associated with enhanced
oxidative phosphorylation [13–17]. Such transcriptional changes may trigger mitochondrial
biogenesis, increasing the oxidative capacity of the muscle, enhancing beta-oxidation
and ultimately sparing muscle glycogen, all of which could lead to enhanced endurance
performance. It has been demonstrated that such high fat, low carbohydrate interventions
can substantially increase fat oxidation during prolonged cycling [16]. However, high
intensity exercise performance subsequent to such dietary manipulation is unlikely to be
enhanced, and may even be compromised [16,18–20] in the absence of glycogen restoration.
Recently, Impy et al. [21] proposed a ‘glycogen threshold hypothesis’, indicating that an
optimal glycogen level may be required to optimise adaptive responses to endurance
exercise. However, understanding the glycogen cost of habitual training is challenging and
a limiting factor in prescribing optimal glycogen-periodisation strategies.
Interventions to reduce carbohydrate intake in endurance athletes tend to substitute
in dietary fat to maintain adequate energy intake. However, adherence to such diets
for moderate periods of time >5-days diets can be poorly tolerated [22]. An alternative
approach to maintain energy intake, but reduce carbohydrate consumption is to substitute
dietary carbohydrate for protein. Under resting conditions in young healthy males, a
high-protein, low-carbohydrate, hypocaloric diet has been shown to significantly increase
AMPK, PPAR and PGC-1α expression [23]. Similar findings have been observed in obese
individuals fed a high-fat, low-carbohydrate hypocaloric diet [10]. This suggests that under
acute metabolic stress (e.g., caloric restriction or carbohydrate availability) preferential
adaptations in cellular metabolic processes may occur subsequent to acute dietary intake
modifications [6]. This also infers that different interventions delivering an external stress
can be utilised to initiate beneficial metabolic adaptations. One such method to elicit
additional external stress alongside endurance training may be by increasing dietary
protein as a substitute for carbohydrate; however, there is a paucity of literature describing
the response to this. It is also currently unknown how if adaptation to acute metabolic
stress may persist, and the impact of removing acute dietary stress on such adaptations.
Therefore, the aim of this study was to investigate the impact of a highly controlled
short-term high-protein, reduced-carbohydrate (PRO) or a high-carbohydrate (CHO) diet
in combination with endurance training on transcriptional biomarkers, fuel utilisation and
exercise performance in trained male runners. It was hypothesised that PRO diet in combi-
nation with endurance training would increase the expression of transcriptomic markers of
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mitochondrial biogenesis, which would be sustained following return to habitual dietary
intake. It was also hypothesised that no difference in high intensity endurance performance
would be observed after the intervention diets, but upon return to habitual dietary intake
the PRO intervention would demonstrate an improved performance due to maintained
adaptation and restored glycogen availability.
2. Materials and Methods
2.1. Participants
This study was conducted in accordance with the Declaration of Helsinki (2013), and
the protocol was approved by the University of Hertfordshire Life and Medical Sciences
Ethics Committee (protocol number LMS/PGR/UH/02227). Following a study briefing
and suitability interview, participants were invited to take part. Power calculation assess-
ment for sample size (G *power3, Dusseldorf) using α = 0.05; 1β = 0.80; based on observed
data of PGC-1α mRNA expression [9] indicated that a total of 6 participants were required
per group. All participants were required to be male and between the age of 18–45 years,
and were recruited through local running clubs, and research team network. From an
initial pool of twenty individuals, three withdrawals were unrelated to the trial, and one
did not complete the second trial and was excluded from subsequent analyses. Therefore,
sixteen healthy, trained male volunteers completed this study (participant characteristics
are shown in Table 1 according to allocated test group). Written informed consent was ob-
tained from all participants included in the study. All participants were required to be free
from any medical condition which would conflict with the study parameters. Additionally,
all participants were required to refrain from following a restrictive dietary regime, suffer
from any known food allergies or intolerances, and be prepared to consume a controlled,
prescribed dietary intake for each trial period. For training suitability, all participants
needed to have completed 10-km in sub-38 min or 5-km in sub-18 min in the previous
12 month period, with a running history >2 years, training ≥4 times per week with no
significant change in training load or body mass in the previous 3 months.














PRO (n = 8) 25 ± 4 179.4 ± 6.4 69.5 ± 3.3 4.38 ± 0.35 63.1 ± 4.8
CHO (n = 8) 27 ± 5 181.6 ± 3.5 67.6 ± 6.1 4.39 ± 0.28 65.3 ± 6.4
PRO: high protein diet; CHO: high carbohydrate diet.
.
VO2max: maximal oxygen uptake. No differences observed between groups (p > 0.05).
2.2. Experimental Design and Procedures
In an investigator-blinded, parallel-groups, repeated-measures design, participants
were randomly assigned to either: PRO (n = 8; total energy intake macronutrient distri-
bution of 40% protein, 30% carbohydrate, and 30% fat) or energy-matched CHO (n = 8;
macronutrient distribution of 10% protein, 60% carbohydrate, and 30% fat). Participants
were not informed of group allocation; however, due to the nature of dietary interven-
tion studies it was not possible to blind food items. Participants attended the Human
Performance Laboratory (GlaxoSmithKline, Brentford, UK) for baseline testing and a fa-
miliarisation session, followed by three experimental sessions (T1, T2, T3). Participants
followed their habitual dietary intake for 7-days prior to completing T1, after which they
followed their prescribed intervention diet (PRO or CHO) for 7-days prior to T2, and finally
returned back to their habitual dietary intake for a further 7-days prior to T3. Participants
were requested to complete the same training sessions each week throughout the duration
of the study and rest the day prior to each test visit. All experimental procedures were
completed in the same order and time of the day.
Baseline and Familiarisation Session: All testing was completed in a temperature-
controlled room (TISs Sport Science environmental chamber) set at 20 ◦C and 40% humidity
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(averaging 20.7 ± 0.8 ◦C, 41.3 ± 5.0% humidity and 1010.0 ± 13.6 mmHg air pressure
across the trials) using the same treadmill (Cosmed T170, Cosmed, Rome, Italy), which was
not moved throughout the experimental period. Fan cooling was provided throughout all
testing, with a floor fan positioned 50 cm in front of the treadmill at a 45◦ angle and set to
an air speed of ~5.8 m·s−1. Prior to assessment of maximal oxygen consumption (
.
VO2max),
participants rested for 5-min, after which height (mechanical stadiometer, Seca 216, seca
Ltd., Hamburg, Germany) and weight (digital column scale, Seca 704) were recorded and
a heart rate (HR) belt fitted (Polar T31 Coded, Polar Electro Ltd., Warwick, UK). A 20 µL
resting, capillarised, fingertip blood sample was then collected, and participants then
undertook a standardised 5 min warm up at a running speed of 9 km·h−1.
The protocol for the assessment of
.
VO2max was the same for all participants. A breath-
by-breath online gas analyser (Metalyzer 3B, Cortex, Leipzig, Germany) was used to capture
continuous respiratory measures. Criteria for the attainment of
.
VO2max complied with that
outlined by the British Association of Sport and Exercise Sciences (BASES—[24]). Following
a 20 min recovery period, participants completed a 5 km steady state (SS) familiarisation




VO2max) in a similar manner to the 10 km SS exercise
trial detailed below. Once completed, participants had 5 min recovery before completing
a maximal sustainable effort at 95%
.
VO2max (calculated from the previous
.
VO2max test)
following the protocol detailed below. Prior to departure, participants were familiarised
with all other testing procedures, and provided with a food diary and a GPS watch
(Garmin Vivo Active, Garmin Ltd., Schaffhausen, Switzerland) to log dietary intake and
training volume.
Assessment of Habitual Dietary Intake: A 3-day food diary based on estimated
household measures was used [25] to collect habitual dietary intake prior to T1 and T3.
During the study briefing, the participants were instructed how to complete the food diary
and were provided with a comprehensive example. The importance of accuracy and detail
was emphasised (e.g., item weight, portion size, meal breakdown, and fluid intake) as
was the importance of maintaining current dietary habits and documenting all food and
drink consumed. Participants were requested to record dietary intake on 2 weekdays and 1
weekend day in the 7-day period preceding T1 and T3 to estimate habitual intake. All food
diaries were analysed by the same researcher using Nutritics Professional Dietary Analysis
software (Nutritics Ltd., Co., Dublin, Ireland).
Assessment of Training Volume: It was important that any observed changes were due
to the intervention diet and not due to change in training volume. Therefore, participants
were requested to maintain the same weekly training programme throughout the study
and were requested to replicate, as closely as possible, each training session on the same
day and time each week, logging all training sessions with the GPS watch provided. The
training sessions were automatically uploaded online (Garmin Connect, Garmin Ltd.,
Schaffhausen, Switzerland) for the investigative team.
Caloric Intake and Intervention Dietary Prescription: Individual calorie intake for the
intervention diet was prescribed to match energy expenditure, and was calculated using
basal metabolic rate (BMR) multiplied by a physical activity factor (PAF). The equation of
Henry [26] was used to estimate BMR. The PAF was quantified based on occupational and
exercise level factors using a modified Harris and Benedict [27] equation, incorporating
estimated non-exercise activity thermogenesis.
A total of 34 diet plans (17 CHO, 17 PRO) were formulated by the investigative team,
starting at 1800 kcal·d−1 and increasing by 150 kcal·d−1 for each plan up to 4200 kcal·d−1.
Participants were assigned the diet closest to their calculated interventional energy intake.
The greatest difference between estimated intervention diet and prescribed diet was 75
kcal per day. All meals were produced by Soulmatefood® (Waterfoot, Lancashire, UK)
and delivered to each individual participant in two batches (a 3-day then a 4-day supply).
Daily food packages consisted of 5 pre-packaged/cooked meals (breakfast, morning snack,
lunch, afternoon snack and dinner). Matching energy intake to energy expenditure is
challenging [25] and it was important that the participants were not in a negative energy
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balance for this study. Therefore, in addition to the calculated dietary intake, a further
500 kcal·day−1 macronutrient-matched meal was provided. Included with the delivery
was a daily menu with consumption instructions and participants were briefed that the
additional meal was only to be consumed if still hungry after consuming the standard
diet and were required to document if the additional meal was consumed. Participants
were requested to remain hydrated through the day, only consume foods provided and
requested to drink water ad libitum or drinks free from caffeine or additional energy. The
mean dietary intake for both prescribed diets is shown in Table 2.
Table 2. Calculated mean dietary intake and macro-nutrient breakdown for each group during the 7-day intervention.
Group
Energy Intake Carbohydrate Protein Fat
kcal·d−1 kcal·kg−1·d−1 g·d−1 g·kg−1·d−1 g·d−1 g·kg−1·d−1 g·d−1 g·kg−1·d−1
PRO 3185 ± 84 48 ± 1.2 239 ± 6.3 3.4 ± 0.9 319 ± 8.4 4.6 ± 0.1 106 ± 2.8 1.5 ± 0.04
CHO 3281 ± 69 49 ± 1.0 492 ± 10.4 * 7.3 ± 0.1 * 82 ± 1.7 * 1.2 ± 0.03 * 109 ± 2.3 1.5 ± 0.03
Prescribed dietary intake (mean ± S.E.) based on estimated energy requirements. PRO = high protein/reduced carbohydrate diet
(40/30/30—protein, carbohydrate, fat ratio); CHO = high carbohydrate/typical protein diet (60/10/30—carbohydrate, protein, fat ratio).
* denotes significant difference between groups (p ≤ 0.002).
Experimental Laboratory Sessions (T1–T3): After a rest day from exercise and follow-
ing a standardised pre-testing protocol, participants arrived at the laboratory at the same
time of day for each visit. Participants were advised to arrive at the laboratory using the
same mode of transport and requested to refrain from morning physical exertion. Upon
arrival, body composition assessment (dual energy x-ray absorptiometry (DXA) scan) was
undertaken, followed by a resting micro muscle-biopsy. Participants then completed a
10-km treadmill run at 75%
.
VO2max, had 5-min rest, then completed a time to exhaustion
(TTE) running trial at 95%
.
VO2max.
Body Composition Assessment: Following measurement of fasted body mass (BM),
participants were requested to remove any metal piercings prior to having a full body
DXA scan (GE Lunar iDXA, GE Healthcare, Bucks, UK). The DXA scan was performed
in accordance with manufacturer’s guidelines for patient positioning and analysed using
enCORE Software, version 14.10 (GE Healthcare, Bucks, UK). All scans were performed by
the same operator. Results were analysed for fat mass (FM) and fat free mass (FFM).
Micro Muscle-Biopsy: Muscle biopsies were obtained from the midpoint on the lateral
aspect of the right vastus lateralis muscle. The biopsy site was cleaned using Betadine
(Pardue Products, Stamford, CT, USA) and samples were obtained under local anaesthesia
(2 mL of 1% v/v without adrenaline, Lidocaine Hydrochloride (Hameln Pharmaceuticals:
cat. no PL01502) injected into the subcutaneous fat of the selected biopsy site). Following
insertion of a 14-gauge co-axial needle ~2 cm into the muscle, a disposable core biopsy
instrument (TSK Stericut Biopsy Needle 14 Gauge, TSK Laboratories, Tochigi-Shi, Tochigi-
Ken, Japan) was inserted through the co-axial and activated. A single biopsy pass was used
collecting ~15–20 mg of muscle tissue. The biopsy instrument was immediately removed,
and within 10 s the muscle tissue was removed from the biopsy instrument using a sterile
scalpel and flash frozen in liquid nitrogen. The muscle sample was placed in an individual
vial and stored at −80 ◦C until analysis (HTA license number 12202).
10-km Steady State Treadmill Run: Following a resting 20 µL capillary blood sample,
participants completed a standardised 5 min warm up at 10 km·h−1 on the treadmill,
followed by self-directed stretching. Along with a HR monitor, participants were fitted
with an oro-nasal facemask in the same manner as the
.
VO2max test, connected to an online
gas analyser for breath-to-breath assessment of respiratory measures. The steady state
10 km run was calculated to be performed at 75%
.
VO2max, with a rolling start (calculations
post-trial indicated an average of 75.6 ± 2.6%
.
VO2max with no difference between groups
observed: PRO = 76.4 ± 3.2%; CHO = 74.7 ± 2.4%, p > 0.05). After each kilometre, stan-
dardised prompts were provided to participants along with collection of a capillary blood
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sample and assessment of HR and rated perceived exertion [28]. Rates of carbohydrate and




VCO2 data using stoichiometric
equations [29], with protein oxidation assumed negligible.
Time to Exhaustion (TTE) Trial: Following a 5 min recovery period, participants then
performed a maximal sustainable effort (MaxSE) test at a speed equivalent to 95%
.
VO2max.
No visual or audible encouragement was permitted throughout the trial. Participants ran
until volitional fatigue, upon which a final capillary blood sample was collected. The same
investigator timed all TTE efforts throughout the study.
2.3. Quantitative PCR (qPCR) Preparation and Analysis
RNA Isolation: Human muscle biopsies were homogenised in 700 µL MagNA Pure LC
RNA Isolation Tissue Lysis buffer (Roche, Mannheim, Germany) in Roche MagNA Lyser
Green bead tubes at 6500 rpm for 30 s. After homogenisation, the tubes were centrifuged for
10 min at 13,000× g before 350 µL of each homogenate was used for RNA extraction. Total
RNA was extracted using the MagNA Pure 96 Cellular RNA Large Volume Kit on a MagNA
Pure 96 (Roche, Mannheim, Germany), in an elution volume of 50 µL according to the
manufacturer’s protocol. RNA was stored at−80 ◦C. RNA concentrations were determined
(A260) using a NanoQuant plate on a Tecan Infinite 200PRO. RNA quality (RNA integrity
number equivalent, RINe) was assessed using RNA ScreenTape on a 2200 TapeStation
(Agilent, Santa Clara, CA, USA).
Reverse Transcription (RT): As a result of the large sample number and the automated
process, RNA concentration was not taken into account for each individual reaction. Four-
teen µL of each RNA sample was reverse transcribed in a total volume of 20 µL using the
High capacity cDNA reverse transcription kit (without RNase inhibitor, Applied Biosys-
tems, Thermo Fisher, Loughborough, UK). The average RNA concentration across the
142 samples was 32.4 ng·µL−1 equating to an average of 453 ng RNA/reverse transcription
reaction. Reactions were performed in 96 well PCR plates on a PTC-225 Peltier thermal
cycler (MJ Research, St. Bruno, Quebec, Canada) using the following profile: 25 ◦C for
10-min, 37 ◦C for 60-min, 85 ◦C for 5-min, 4 ◦C hold. Minus RT control reactions were set
up for 14 samples, in which the RNA component was replaced with nuclease free water
(Ambion, Fisher Scientific, Loughborough, UK).
qPCR Analysis: For quantitative real-time PCR (qPCR), Human TaqMan® gene expres-
sion assays were purchased as a 20× assay ready stock from Life Technologies (Carlsbad,
USA) (primers 18 mM and probes 5 mM) (Table 3). One µL cDNA was added to each
qPCR reaction mixture which also contained gene expression assay mix (primers 900 nM
final, probe 250 nM final), LightCycler 480 Probes Master and nuclease free water to give a
5 µL total reaction volume. Reactions were prepared in white multiwell 384 plates (Roche,
Mannheim, German) using a Mosquito HV (TTP Labtech, Melbourn, UK). The plates were
sealed using optical seals (Roche, Mannheim, Germany) and centrifuged at 290× g for
2 min before being run on a LightCycler® 480 instrument (Roche, Mannheim, Germany)
with the following thermal cycling parameters: initial de-naturation step 95 ◦C for 10 min,
followed by 45 cycles of denaturation at 95 ◦C for 10 s and primer annealing/extension at
60 ◦C for 30 s. A cooling step at 40 ◦C for 30 s was the final stage of the run. The crossing
point (Cp) value for each sample was calculated using the second derivative maximum
method applied directly by the Roche software to the real-time amplification curves. This
value represents the cycle at which the increase of fluorescence is highest and where the
logarithmic phase of a PCR begins.
Amplification Efficiency of qPCR Assays: The efficiency of each of the Taqman® assays
on demand was confirmed by performing standard curves in a 384 well qPCR assay on the
LightCycler® 480 under the same conditions described above. Six point standard curves
with 1 in 10 serial dilutions were prepared in nuclease free water for human plasmid DNA
for each of the genes being tested alongside Human genomic DNA with a top concentration
of 3 × 105 copies/µL and 1 × 105 copies/µL, respectively. qPCR reactions were performed
in triplicate and the amplification efficiency calculated for each Taqman® assay on the
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basis of the equation E = (10 − 1/slope − 1) × 100 with the logarithm of the template
concentration on the x axis and the average Cp plotted on the y axis.
Table 3. Taqman Assays on Demand information (Applied Biosystems).
Gene Name Gene Abbreviation Assay on Demand Number
Peroxisome proliferator-activated receptor gamma coactivator
1-alpha (PGC-1α) PPARGC1 Hs01016719_m1
AMP-activated protein kinase 1 (AMPK) PRKAA1 Hs01562315_m1
Peroxisome proliferator-activated receptor delta (PPARδ) PPARδ Hs00987011_m1
Silent information regulator-T1 (SIRT1) SIRT1 Hs01009005_m1
Silent information regulator-T3 (SIRT3) SIRT3 Hs00953477_m1
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) GAPDH Hs99999905_m1
Data Analysis of the qPCR Assays: The muscle biopsy qPCR raw Cp values were
exported and normalised to the housekeeper gene (GAPDH) using an analysis of co-
variance method. Relative fold change in expression levels were calculated using the
2-∆∆CT method.
2.4. Statistical Analysis
Statistical analysis was conducted using the statistical package for the Social Science
software program (SPSS; version 22, IBM, Armonk, NY, USA). Dependent variable dis-
tributions were assessed for Kolmogorov–Smirnov test of normality, along with visual
inspection of histograms and boxplots. Mauchly’s sphericity test was used to assess the
assumption of sphericity within repeated-measures effects. Unless stated, Mauchly’s test
was not significant, therefore the assumption of sphericity was accepted. Group and time
point effects were assessed using a two factorial mixed design ANOVA (4 groups, 2 time
points) with dietary intake (between) and time point (within) as the main variables. To
determine the location of the time-point differences and group interactions, a Bonferroni
post hoc test was used. Statistical significance was set at p ≤ 0.05. Data presented as
mean ± SEMs (unless stated).
3. Results
3.1. Dietary Intake, Body Composition and Training Data
No significant group interactions or time point differences were observed in habitual
dietary intake, body mass, lean mass or fat mass (p > 0.05), demonstrating energy intake
matched energy requirement during both the dietary intervention and habitual intake
weeks. No within- or between-group differences were observed in total training distance
covered each week (training distance PRO vs. CHO, p = 0.83) across the study period.
However, a significant reduction in average running speed was observed between T1
(14.7 km·h−1) and T2 (13.8 km·h−1) in the PRO group (p = 0.047, Table 4). Once reverted
back to habitual diet, average training speed for PRO in T3 was 14.2 km·h−1.














PRO 51 ± 26 14.7 ± 1.7 51 ± 28 13.8 ± 1.5 * 50 ± 28 14.2 ± 1.3
CHO 62 ± 20 13.9 ± 0.8 64 ± 24 14.1 ± 1.4 65 ± 22 13.9 ± 0.9
* Denotes significant difference to T1 within group (p = 0.047).
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3.2. Transcription Biomarkers
No change was observed in the resting mRNA content of PGC-1α, SIRT1 and SIRT3
at any time point in either group (Figure 1A,D,E). A within group difference main ef-
fect (p = 0.027) for AMPK mRNA was observed in the CHO group (Figure 1B) and
AMPK mRNA expression was significantly elevated at T2 (1.44 fold increase relative
to T1, p = 0.042), and maintained at T3 (1.57 fold increase relative to T1, p = 0.011). A within
group difference (p = 0.018) was also observed in the PRO group where AMPK mRNA
expression was significantly increased at T2 (1.37 fold increase relative to T1, p = 0.016);
however, this returned to pre-intervention levels by T3 (p = 0.18). PPAR expression in the
CHO group exhibited the same trend as AMPK, with a 1.32 and 1.29 fold increase at T2
(p = 0.029) and T3 (p = 0.044) relative to T1, respectively. No time point difference in PPAR
expression was observed in the PRO group. No changes were observed for SIRT1 or SIRT3
mRNA expression within or between groups (p > 0.05).
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Figure 1. mRNA response (fold change) to habitual and intervention diet phases in combination with endurance training. 
Habitual dietary intake in first (T1) and third (T3) week. Intervention phase (T2) consisting of either high protein (PRO) 
or high carbohydrate (CHO) intake. mRNA expression of PGC-1α (A), AMPK (B), PPAR (C), SIRT-1 (D), and SIRT-3 (E). 
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3.3. Steady State Fuel Utilisation and Related Measures 
In the CHO group, both carbohydrate and fat oxidation remained similar across all 
trials during the 10-km SS trial (p > 0.05, Figure 2B,D). In the PRO group a significant time 
point difference in fat (p < 0.001) and carbohydrate oxidation (p < 0.001) was observed, 
Figure 1. response (fol c a ge) to a it l i t r ti i t i i ti it t i i .
abitual dietary intake in first (T1) and third (T3) week. Interventio phase ( 2) consisti f eit er hi rotei ( )
or high carbohy rate ( ) i ta e. ex ressi f -1 ( ), ( ), ( ), I -1 ( ), a I -3 ( ).
* Denotes significantly different within group from T1 (p < 0.044).
. . tea tate el tilisatio a elate eas res
I t e group, both carbohy rate an fat oxidation re ained si ilar across all
tri l i t 10-k S trial (p > 0.05, Figure 2B,D). In the PRO group a significant
time po nt diff re ce in fat (p < 0.001) nd carbohydrate oxidation (p < 0.001) was ob-
served, where fat oxidation was significantly increased and carbohydrate oxidation was
significantly decreased at each km (1–10 km) collection point in TP2 compared to TP1
(Figure 2A,C, p < 0.0001). Mean fat oxidation following PRO increased from 0.29 ± 0.05
to 0.59 ± 0.05 g·min−1 (p < 0.0001), an increase of 101% relative to T1. Correspond-
ingly, mean carbohydrate oxidation following PRO decreased by 27% from 2.96 ± 0.18
to 2.15 ± 0.19 g·min−1 (p < 0.0001). Both fat and carbohydrate oxidation returned to
pre-intervention levels once reverted back to habitual dietary intake.
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significant difference observed between the intervention diet and T3 (4.1 ± 0.6 and 4.9 ±
0.7 mmol·L−1, p = 0.034), and a trend to difference between T1 and T2 (4.7 ± 0.4 vs. 4.1 ±
0.6 mmol·L−1, p = 0.055). No other differences were observed for PRO, or between groups.
3.4. MaxSE Time Trial Results
The results of the 95% MaxSE trial are shown in Figure 4A,B, expressed as relative
change (%) from T1. Following PRO, TTE was significantly reduced within group by 23.3%
at T2, with all participants exhibiting decreased ability to perform (p = 0.0003). Upon
subsequent return to habitual dietary intake, TTE for PRO at T3 was comparable to T1
(T1: 128.3 ± 29.3 s, T2: 98.4 ± 31.8 s, T3: 125.3 ± 32.39 s). In contrast, significant (p = 0.05)
within group change of +6.5% in TTE at T2 was noted in the CHO group with 7 of the
8 participants improving relative to TP1. TTE performance for CHO also returned to pre
intervention levels by T3 (T1: 182.2 ± 44.4 s, T2: 194 ± 45.5 s, T3: 184 ± 38.9 s). A between
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group effect in TTE was observed (p = 0.017), with no relative difference reported at T1 or
T3, but at T2 there was a significant relative difference in performance (p < 0.0001).
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Figure 4. Mean (bar) and individual (line) relative change (%) from pre-intervention maximal sustainable effort test. Time
trial to exhaustion (TTE) from a 95% MaxSE trial. Habitual dietary intake in first (T1) and third (T3) week. Intervention phase
(T2) consisting of either: (A) high protein (PRO) or (B) high carbohydrate (CHO) intake. * = significant mean difference
(p < 0.05) compared to T1.
4. Discussion
In the present study, we determined the impact of a short-term period of either high
PRO or CHO dietary intake in trained male runners under controlled conditions on tran-
scription biomarkers of mitochondrial biogenesis, sub-maximal substrate utilisation and
high intensity exercise performance. It was hypothesised that a high PRO diet, due to
carbohydrate reduction, would positively impact resting transcription biomarkers of mito-
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chondrial biogenesis including an up-regulation of PGC-1α, AMPK and SIRT-1 and such
adaptations may be sustained following return to habitual dietary intake. However, the re-
sults from the study did not show this, as the gene mRNA expression of the transcriptional
biomarkers following the PRO intervention were predominantly insignificant.
Findings from the study demonstrated that following PRO, a significant and profound
reduction in high intensity TTE was observed, and this was seen in all participants. The
moderate increase in resting AMPK expression observed at T2 corresponded with a sig-
nificant increase in fat oxidation rates during sub-maximal 10 km exercise. Whilst such
changes may have implications for endurance training, AMPK returned to pre-intervention
levels upon return to habitual intake, as did substrate utilisation. Thus, a lack of responses
in other transcription biomarkers following PRO, as well as a return to pre-intervention
performance levels following the second habitual dietary period infer that any beneficial
impact of a short-term PRO diet on fuel utilisation may be limited to energy availability.
This coupled with the highly significant and inclusive reduction in high intensity running
performance suggests that PRO regime is likely not to be preferential for endurance athletes
seeking to optimise performance.
By reducing carbohydrate intake below habitual levels, but maintaining energy intake,
it was expected that a short-term cellular energy demand would be challenged in favour
of an up-regulation of SIRT-1 and AMPK leading to greater expression of PGC-1α at rest.
This, however, did not occur, suggesting that during periods of endurance training, ath-
letes may have limited gene transcription benefits from consuming an acute high protein,
carbohydrate-reduced diet. In a similar manner to low-carbohydrate high-fat diets, the
increase in steady state fat oxidation observed in the PRO group is not unexpected, con-
sidering the reduced dietary carbohydrate availability. Thus, different diets which reduce
habitual carbohydrate intake below individual thresholds for daily glycogen repletion,
may lead to a metabolic ‘shift’ towards increased beta-oxidation to meet energy demands.
It is likely such changes in respiratory exchange ratio reflect substrate availability rather
than true adaptations within the muscle [14]. Furthermore, it is important to consider
the amplitude of change observed in the resting gene expression levels. Post exercise, a
>10-fold increase in such genes has been previously observed [13], whereas in the current
study we observed <1.5 fold increased in selected gene expression. As limited literature
exists reporting resting expression of such genes in training studies the finding of this
study provides novel insight into the short term adaptive response. However, with such
small, but in some cases significant, changes in gene expression, the interpretation should
be viewed with caution and further work is required to fully establish the importance of
these findings.
In contrast to a high PRO diet, participants following the CHO condition had a
mean increase in both AMPK and PPAR expression (of similar 1.5 fold amplification),
which was sustained within-group following return to habitual dietary intake. Despite
no changes in sub-maximal substrate utilisation following CHO, a small but significant
(6.5%) improvement in high intensity running performance was noted at T2. Furthermore,
it was observed that training intensity during CHO was maintained (no difference in
weekly average speed). However, following the PRO intervention, these participants
exhibited a reduction in mean training intensity (average speed decrease of 0.9 km·h−1),
which may seem minimal, but a 1 km·hr−1 reduction in running speed would equate to
a 10 km time approximately 2 min 30 s slower (at the speeds the participants perform
at). It is feasible, therefore, that this reduction in training intensity reduced the cellular
stress in the PRO group compared to CHO. Indeed, this may explain why transcription
biomarkers were sustained at T3 in the CHO group. The inclusion of a high carbohydrate
approach (60% of energy intake) may have favoured greater glycogen recovery between
training bouts enabling the maintenance on training intensity, which ultimately increases
metabolic stress and is likely to be the main mechanism stimulating the observed training
adaptation. Previously, it has been demonstrated that increasing exercise intensity induces
greater changes in PGC-1α expression [30], suggesting that a reduction in training intensity
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observed subsequent to the PRO intervention is likely be counterproductive to adaptation.
As such, this supports the contention that carbohydrate intake should not be compromised
during periods of moderate to high training volume in experienced athletes, seeking high
levels of athletic performance.
Carbohydrate availability has been shown to impact endurance exercise [31–33]. In-
creasing carbohydrate availability through either glycogen sparing or through improved
efficiency of exogenous provision during sustained exercise has been demonstrated to
enhance endurance performance [34–36]. An increase in habitual carbohydrate intake to
contemporary recommended guidelines (7–12 g·kg−1·d−1, [31]) for trained athletes ob-
served in the current study resulted in maintenance of training volume/maximal sustained
performance. The exercise-induced changes in energy-sensing mechanisms during periods
of regular endurance training may provoke sustained adaptations in both AMPK and PPAR
mRNA. Moderate to high intensity endurance exercise is known to increase AMPK activity
due to metabolic stress and accelerated ATP demand. In the presence of adequate carbo-
hydrate provision, the up-regulation in AMPK and PPAR mRNA observed in the current
study may be associated with higher GLUT-4 and hexokinase activity [37] as opposed to
mitochondrial biogenesis. As such, the combination of higher carbohydrate intake, coupled
with regular endurance training may have favoured adaptations associated with glucose
metabolism and sustained carbohydrate oxidation rates. For athletes undergoing demand-
ing or high-volume endurance training where performance maintenance is important, this
study indicates that a high CHO approach may be fundamental to this process.
Uniquely, in this study, dietary substitution of high protein (not fat) was employed
during the reduced carbohydrate phase. The high PRO intervention significantly impacted
fuel utilisation during sustained endurance exercise, with mean peak fat oxidation rates
reaching 0.59 g·min−1. The authors knowledge that this is the first time such changes
following a high PRO approach have been reported. These findings are similar to those
previously reported subsequent to a high fat, low carbohydrate diet [16], where mean
fat oxidation reached 0.6 g·min−1 during sub-maximal cycling. Short term reductions in
carbohydrate intake below habitual levels by either increasing dietary fat or protein intake
has similar effects on respiratory exchange ratio during sub-maximal exercise, suggesting
that it is carbohydrate availability, rather than the increase in either dietary fat or protein,
which dictates fuel utilisation during sub-maximal exercise. The longer-term use of high fat
approaches, leading to short-term fat adaptation [14,38] or the longer-term ‘keto-adaptation’
response [39], compared with longer-term use of high protein phases is warranted to assess
metabolic changes during sustained training periods.
Whilst PRO in the current study was found to reduce carbohydrate and increase fat
utilisation during a 10 km steady state treadmill run, it is important to remember that high
intensity performance was compromised at T2. Furthermore, the return to pre-intervention
levels for transcription biomarkers, along with a ‘normalisation’ in fuel efficiency by T3
(habitual intake) indicates that there are limited, if any, performance benefits of consuming
a high PRO (reduced carbohydrate) diet for 7-days. Whilst the use of PRO may confer
positive benefits in terms of fuel efficiency, such findings should be interpreted with caution.
Endurance athletes who are looking at manipulating dietary intake during moderate-high
intensity training may be better to adopt other feeding regimes, such as short-term low
glycogen availability periods, followed by carbohydrate restoration to minimise both
training disruptions and/or performance decrements [21].
4.1. Applications
Endurance exercise is a potent stimulator of PGC-1α via the AMPK-SIRT1 pathway [40,41],
and increases in PGC-1α expression have been observed following a single bout of en-
durance exercise [13]. This response can be further amplified when in a single exercise
bout in a low glycogen state [42,43]. Furthermore, it has been demonstrated in vitro [8] and
in vivo [10] that reduced glucose and/or nutrient availability promote increased PGC-1α,
AMPK and SIRT1 mRNA expression. In untrained individuals over a 14-day training
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period, Perry et al. [13] found a transient post-exercise response in PGC-1α expression,
observing a 10-fold increase in PGC-1α mRNA expression subsequent to the first bout
of endurance cycling, which was reduced to a 4-fold increase after the seventh training
session. In addition, with adequate glycogen availability, Psilander et al. [43] found a
2.5-fold increase in PGC-1α mRNA expression following a single bout of endurance cycling
in well-trained cyclists (
.
VO2max = 65.4 ± 0.9 mL·kg−1·min−1), and with the addition of
glycogen restriction to the endurance session, an 8.1-fold increase in expression; similar
to that observed in untrained individuals [13]. These data sets suggest that the transcrip-
tional adaptive response is blunted when skeletal muscle becomes accustomed to the
exercise stress, and increasing the metabolic stress by restricting glycogen availability may
result in enhanced post exercise transcriptional adaptation to a single one-off exercise
bout. However, these studies examine the impact of carbohydrate restriction after a sin-
gle bout of exercise. The results from the current study provide a different perspective
on the adaptive response and performance outcomes using such nutrient manipulation
models, as carbohydrate restriction was prolonged for 7 days. The data does not support
the use of repeated days of carbohydrate restriction on training adaptation and exercise
performance, demonstrating that reduced carbohydrate availability, without repletion,
during a typical training week resulted in a significant decrease in exercise performance
and no discernible improvement in resting PGC-1α mRNA expression. Thus, it is likely
the PRO intervention utilised in this trial is not a positive method to implement to improve
endurance performance.
4.2. Study Limitations
An important consideration is that post exercise muscle biopsies were not collected
in the current study. However, the results from our previous research [23], along with
others [10], demonstrate that mRNA expression is sensitive to dietary manipulation at
rest. In addition, Baar et al. [12] found that PGC-1α protein responds similarly to mRNA
expression, thus an assumption can be made that an increase in mRNA expression is
accompanied by increased protein content. Additionally, despite initial power calculation,
the effect size of the mRNA expression is fairly small, thus a larger sample size may be
warranted to further validate these findings. As such these aspects of the results should be
interpreted with due consideration.
Furthermore, muscle glycogen was not measured, however seminal work from
Bergstrom et al. [44] demonstrated that consuming a very low carbohydrate diet for 7-days
without exercising resulted in a 32% reduction in muscle glycogen. Thus, it is fair to as-
sume that the high protein intervention, in combination with endurance training, resulted
in significant reductions in muscle glycogen. The significant reduction in resting blood
glucose, and increase in fat oxidation, during the sub-maximal trial in the high protein
group corroborate this further.
5. Conclusions
In trained male runners and in combination with habitual training, a 7-day high
protein diet significantly increases fat oxidation during sub-maximal exercise, but sig-
nificantly compromised training intensity and high-intensity running performance. In
contrast, training intensity was not impacted subsequent to a 7-day high carbohydrate diet,
and neither was sub-maximal substrate utilisation, but an improvement in high-intensity
running performance was observed. The high carbohydrate diet also resulted in greater
changes in resting muscle AMPK and PPAR expression, which remained elevated on return
to habitual diet. These findings suggest that consuming a high protein, low carbohydrate
diet for 7-days results in decreased exercise performance and does not enhance training
adaptation, thus is not a preferred intervention for endurance athletes to adopt.
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